Blar i Institutt for klinisk og molekylær medisin på forfatter "Ødegård, Rønnaug Astri"
-
Anthropometrics of neonates born to mothers with PCOS with metformin or placebo exposure in utero
Nilsen, Guro Ørndal; Simpson, Melanie Rae; Hanem, Liv Guro Engen; Løvvik, Tone Shetelig; Ødegård, Rønnaug Astri; Stokkeland, Live Marie T; Andersen, Marianne; Juliusson, Pétur Benedikt; Vanky, Eszter Ilona (Peer reviewed; Journal article, 2023)Introduction Fetal growth may be affected by both maternal polycystic ovary syndrome (PCOS) and metformin therapy. Here, we explore the effect of intrauterine metformin exposure on birth anthropometrics of infants born ... -
Camp-based family treatment of childhood obesity: randomised controlled trial
Benestad, Beate; Lekhal, Samira; Småstuen, Milada C; Hertel, Jens Kristoffer; Halsteinli, Vidar; Ødegård, Rønnaug Astri; Hjelmesæth, Jøran (Peer reviewed; Journal article, 2017)Objective To compare the effectiveness of a 2-year camp-based family treatment programme and an outpatient programme on obesity in two generations. Design Pragmatic randomised controlled trial. Setting Rehabilitation ... -
Early Gut Fungal and Bacterial Microbiota in Growth and Allergy-Related Diseases
Schei, Kasper (Doctoral theses at NTNU;2021:204, Doctoral thesis, 2021)TIDLEG SOPP- OG BAKTERIEMIKROBIOTA I VEKST OG ALLERGIRELATERTE SJUKDOMMAR BARNETARMFLORA I VEKST- OG ALLERGIUTVIKLING Det er ikkje tvil om at tarmflora er i vinden for tida. Endeleg har forskarar kunna djupdukke ned i ... -
Kalorirestriksjon hos barn og unge i fedmebehandling; variasjon i motreguleringsrespons for hvilemetabolisme og spiseatferd
Hagenes, Marie; Åstebøl, Martine (Master thesis, 2017)Bakgrunn: Forekomsten av fedme hos barn og unge er økende, mens fedmebehandling hos barn og unge er i dag ineffektiv og lite differensiert. Kroppslige motreguleringsmekanismer så som reduksjon i hvilemetabolisme aktiveres ... -
Metformin in pregnancy and long-term health of children of women with polycystic ovary syndrome
Hanem, Liv Guro Engen (Doctoral theses at NTNU;2019:187, Doctoral thesis, 2019)Metformin i svangerskap og langtidshelse hos barn av mødre med polycystisk ovariesyndrom (PCOS) Polycystisk ovariesyndrom (PCOS) er en vanlig tilstand hos kvinner i fertil alder, med en prevalens på rundt 15%. PCOS gir ... -
SPIOMET4HEALTH—efficacy, tolerability and safety of lifestyle intervention plus a fixed dose combination of spironolactone, pioglitazone and metformin (SPIOMET) for adolescent girls and young women with polycystic ovary syndrome: study protocol for a multicentre, randomised, double-blind, placebo-controlled, four-arm, parallel-group, phase II clinical trial
Garcia-Beltran, Cristina; Malpique, Rita; Andersen, Marianne S; Bas, Firdevs; Bassols, Judit; Darendeliler, Feyza; Díaz, Marta; Dieris, Barbara; Fanelli, Flaminia; Fröhlich-Reiterer, Elke; Gambineri, Alessandra; Glintborg, Dorte; López-Bermejo, Abel; Mann, Christopher; Marin, Silvia; Obermayer-Pietsch, Barbara; Ødegård, Rønnaug Astri; Ravn, Pernille; Reinehr, Thomas; Renzulli, Matteo; Salvador, Cristina; Singer, Viola; Vanky, Eszter Ilona; Torres, Juan Vicente; Yildiz, Melek; de Zegher, Francis; Ibáñez, Lourdes (Peer reviewed; Journal article, 2023)Background: Polycystic ovary syndrome (PCOS) is the most prevalent, chronic endocrine‑metabolic disorder of adolescents and young women (AYAs), affecting 5–10% of AYAs worldwide. There is no approved pharmacological therapy ...